B001 in Patients With CD20 Positive B-cell Non Hodgkin's Lymphoma
Clinical trial NCT03332121 · COMPLETED
Trial details
- NCT number
- NCT03332121
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-22
- Primary completion
- 2020-11-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.